Linking Ubiquitin Research to Drug Discovery

Home » News & Events » News » Ubiquitin focused drug discovery

Ubiquitin focused drug discovery

Targeting kinase enzymes has grown to dominate drug discovery over the last decade, accounting for 30% of current pharma R&D

Click on the link below to download our brochure detailing “The Unbiquitin System” and how “The analogous ubiquitin cell signalling system is the next big opportunity beyond kinases representing greater therapeutic reach.”

DUBtarget-001 non-confidential summary download here

To find out more information about Integrated Drug Discovery read more

If you’re interested in exploring how you can access the DUBtarget-001 DUB targeted library please Contact us directly.

 

Posted on August 3rd, 2017 in News